Journal of Indian Association of Pediatric Surgeons
Journal of Indian Association of Pediatric Surgeons
                                                   Official journal of the Indian Association of Pediatric Surgeons                           
Year : 2021  |  Volume : 26  |  Issue : 4  |  Page : 223--227

Results of injection sclerotherapy with bleomycin in pediatric lymphatic malformations


Vipan Kumar1, Subhasis Roy Choudhury1, Partap Singh Yadav1, Vikram Khanna1, Amit Gupta1, Rajiv Chadha1, Rama Anand2 
1 Department of Pediatric Surgery, Lady Hardinge Medical College and Kalawati Saran Childrens Hospital, New Delhi, India
2 Department of Radiology, Lady Hardinge Medical College and Kalawati Saran Childrens Hospital, New Delhi, India

Correspondence Address:
Prof. Subhasis Roy Choudhury
Department of Pediatric Surgery, Lady Hardinge Medical College and Kalawati Saran Childrens Hospital, New Delhi
India

Aim: The aim of the study was to evaluate the results of injection sclerotherapy with bleomycin in pediatric patients with lymphatic malformations. Materials and Methods: In this prospective cohort study, all consenting pediatric patients with macrocystic lymphatic malformations were managed with injection bleomycin sclerotherapy (0.5 mg/kg, not exceeding 5 mg at a time) under ultrasound (US) guidance. After aspirating the cyst fluid bleomycin was instilled intralesionally in a ratio of 5:1 (aspirated cyst fluid volume: diluted bleomycin solution volume). Patients were reassessed at three weekly intervals. The response to therapy was assessed clinically as well as by size and volume on ultrasound Doppler study. The response was classified as excellent response, i.e., complete regression, good response >50% regression, and poor response <50% regression. Results: Sixty patients with lymphatic malformations were enrolled in the study, the mean age was 3.22 years, and the male-to-female was 2.5:1. The most common site of lesion was in the neck (43.3%), followed by the axilla (15%) and flank (8.3%). The responses were excellent, good, and poor in 43 (71.6%), 12 (20%), and five (8.3%) patients, respectively. Two patients underwent surgical excision of the residual lesion. Complications noted were fever in six, local pain in five, and residual lesion in three patients. Conclusion: Sclerotherapy with bleomycin is simple, safe, and effective in the first line of management for macrocystic lymphatic malformations in children.


How to cite this article:
Kumar V, Choudhury SR, Yadav PS, Khanna V, Gupta A, Chadha R, Anand R. Results of injection sclerotherapy with bleomycin in pediatric lymphatic malformations.J Indian Assoc Pediatr Surg 2021;26:223-227


How to cite this URL:
Kumar V, Choudhury SR, Yadav PS, Khanna V, Gupta A, Chadha R, Anand R. Results of injection sclerotherapy with bleomycin in pediatric lymphatic malformations. J Indian Assoc Pediatr Surg [serial online] 2021 [cited 2021 Aug 4 ];26:223-227
Available from: https://www.jiaps.com/article.asp?issn=0971-9261;year=2021;volume=26;issue=4;spage=223;epage=227;aulast=Kumar;type=0